DMCCA grants new powers to CMA and expands list of banned practices

As of 6 April, key parts the DMCCA have come into force, including expanded powers for the Competition and Markets Authority (CMA) and updates to Unfair Commercial Practices.

The Digital Markets, Competition and Consumers Act 2024 (DMCCA) has introduced a range of changes to consumer and competition law, and in its aim to provide a level playing field for businesses, it has given the Competition and Markets Authority (CMA) new powers to directly enforce consumer law. This includes the provision of fines. It also introduces new banned practices including a ban of fake reviews.

What is the Digital Markets, Competition and Consumers Act (DMCCA)?

The DMCCA is a piece of legislation brought into UK law dealing with the regulatory landscape for digital markets, competition, and consumer protection. It replaces the Consumer Protection Regulations 2008 (CPRs), adding new banned practices and strengthening existing ones.

What are the CMAs new powers?

The CMA will now be able to decide whether consumer protection laws have been infringed (rather than litigating through the courts) and to tackle any breaches directly and proportionately, including through consumer redress and fines.

The CMA has published an ‘Approach to Consumer Protection’ document which outlines likely priority areas of enforcement and compliance activity. These include providing information to consumers that is objectively false, particularly in relation to the new banned practice relating to fake reviews.

Will the new banned practices impact my advertising?

While fake reviews have always been a breach of the PAGB Consumer Code, the DMCCA introduces an explicit ban on these. This includes writing, submitting, and commissioning another person to provide a fake review. While incentivising reviews is allowed, such as offering consumers a future discount, hiding the fact that a review may have been incentivised is prohibited. This should be disclosed, for example by labelling the review as an advert.

Members should ensure all testimonials remain genuine and retain evidence of this, as well as permission. Consideration must also be given to whether reviews are published in a misleading manner. Examples include removing negative reviews from a brand website or giving greater prominence to positive reviews. Regular monitoring for outdated reviews should also be employed.

The CMA has published a helpful guide on fake reviews here. For advice on implementing consumer reviews in advertising please contact the advertising team at copyclearance@pagb.co.uk.

Related news

Self-Care Week blog post from Mark Burdon

Our final blog post this Self-Care Week delves into the pivotal role that pharmacies are playing in the Government’s 10 Year Health Plan. Mark explores the impact of Pharmacy First paving the way, the current challenges that the Government should be prioritising and how digital tools can bring support pharmacists as they widen access to self-care and help streamline patient journeys.

Self-Care Week blog post from Mark Burdon

Self-Care Week blog post from Michelle Riddalls OBE

To mark Self-Care Week, Michelle Riddalls OBE has authored a blog post on the important role that reclassification has to play in the Government’s agenda to move from sickness to prevention and reduce pressures on primary care. Through greater reclassification of over-the-counter products, we can improve access to self-care, reduce GP visits and empower patients, whilst delivering up to £1.4 billion in savings to NHS prescribing costs annually.

Self-Care Week blog post from Michelle Riddalls OBE
View all